These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33472023)

  • 21. "Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo.
    DeChristopher BA; Fan AC; Felsher DW; Wender PA
    Oncotarget; 2012 Jan; 3(1):58-66. PubMed ID: 22308267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved protein kinase C affinity through final step diversification of a simplified salicylate-derived bryostatin analog scaffold.
    Wender PA; Staveness D
    Org Lett; 2014 Oct; 16(19):5140-3. PubMed ID: 25238640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
    Thangsunan P; Tateing S; Hannongbua S; Suree N
    J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death.
    Staveness D; Abdelnabi R; Schrier AJ; Loy BA; Verma VA; DeChristopher BA; Near KE; Neyts J; Delang L; Leyssen P; Wender PA
    J Nat Prod; 2016 Apr; 79(4):675-9. PubMed ID: 26900625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bryostatin-1 alleviates experimental multiple sclerosis.
    Kornberg MD; Smith MD; Shirazi HA; Calabresi PA; Snyder SH; Kim PM
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2186-2191. PubMed ID: 29440425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ.
    Irie K; Yanagita RC; Nakagawa Y
    Med Res Rev; 2012 May; 32(3):518-35. PubMed ID: 22539107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.
    Staveness D; Abdelnabi R; Near KE; Nakagawa Y; Neyts J; Delang L; Leyssen P; Wender PA
    J Nat Prod; 2016 Apr; 79(4):680-4. PubMed ID: 26900711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
    Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window.
    Sloane JL; Benner NL; Keenan KN; Zang X; Soliman MSA; Wu X; Dimapasoc M; Chun TW; Marsden MD; Zack JA; Wender PA
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10688-10698. PubMed ID: 32371485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered extracellular vesicles encapsulated Bryostatin-1 as therapy for neuroinflammation.
    Wu WC; Tian J; Xiao D; Guo YX; Xiao Y; Wu XY; Casella G; Rasouli J; Yan YP; Rostami A; Wang LB; Zhang Y; Li X
    Nanoscale; 2022 Feb; 14(6):2393-2410. PubMed ID: 35088795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial PKC delta activation attenuates neutrophil transendothelial migration.
    Carpenter AC; Alexander JS
    Inflamm Res; 2008 May; 57(5):216-29. PubMed ID: 18594782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner.
    Mehla R; Bivalkar-Mehla S; Zhang R; Handy I; Albrecht H; Giri S; Nagarkatti P; Nagarkatti M; Chauhan A
    PLoS One; 2010 Jun; 5(6):e11160. PubMed ID: 20585398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
    Kazanietz MG; Lewin NE; Gao F; Pettit GR; Blumberg PM
    Mol Pharmacol; 1994 Aug; 46(2):374-9. PubMed ID: 8078499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV.
    Wender PA; Hardman CT; Ho S; Jeffreys MS; Maclaren JK; Quiroz RV; Ryckbosch SM; Shimizu AJ; Sloane JL; Stevens MC
    Science; 2017 Oct; 358(6360):218-223. PubMed ID: 29026042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase C delta regulates airway mucin secretion via phosphorylation of MARCKS protein.
    Park JA; Crews AL; Lampe WR; Fang S; Park J; Adler KB
    Am J Pathol; 2007 Dec; 171(6):1822-30. PubMed ID: 18055557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin.
    Irie K; Yanagita RC
    Chem Rec; 2014 Apr; 14(2):251-67. PubMed ID: 24677503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adduct formation in liquid chromatography-triple quadrupole mass spectrometric measurement of bryostatin 1.
    Nelson TJ; Sen A; Alkon DL; Sun MK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():55-62. PubMed ID: 24291721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bryostatin-1 promotes long-term potentiation via activation of PKCα and PKCε in the hippocampus.
    Kim H; Han SH; Quan HY; Jung YJ; An J; Kang P; Park JB; Yoon BJ; Seol GH; Min SS
    Neuroscience; 2012 Dec; 226():348-55. PubMed ID: 22986161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating protein kinase C (PKC) delta translocation and preventing PKCdelta-mediated release of tumor necrosis factor-alpha.
    von Burstin VA; Xiao L; Kazanietz MG
    Mol Pharmacol; 2010 Sep; 78(3):325-32. PubMed ID: 20516369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.